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I.  INTRODUCTION 
1.  The protection of health has been made a priority under Articles 3(  o) and  129 of the 
Treaty establishing the European Community.  The Community's role is  to contribute 
towards ensuring a high level of  human health protection, directing actions towards the 
prevention  of diseases,  in  particular  by  encouraging  cooperation  between  Member 
States and, if necessary, lending support to their action, by promoting coordination of 
their policies and programmes, and by fostering cooperation with third countries and 
the international organisations competent in the sphere of  public health. 
2.  In its communication of24 November 1993 on the :framework for action in the field of 
public health (COM (93) 559 final),  the Commission defined a :framework for future 
action at Community level in order to attain these objectives. In accordance with the 
criteria laid  down in the Commission communication pollution-related  diseases  have 
been identified as a priority for Communi_ty action in the field of  public health. 
3.  Pollution-related diseases are those diseases which are caused, provoked or aggravated 
by environmental pollution. In the context of  environmental programmes, pollution has 
been defined as an effect on the environment linked to human activities that disturbs the 
absorption and regeneration of the ecosystem. But in relation to public health a more 
limited definition is that pollution is an environmental imbalance or disturbance, man-
made or naturally occurring, which can have an adverse effect on human health. These 
pollutants may be biological, chemical or physical in nature and may be present in air, 
water, soil or food. -4-
ll.  POLLUTION-RELATED DISEASES IN THE EUROPEAN COMMUNITY 
4.  Environmental  pollution  has  created  problems  for  health  throughout  the  course  of 
human  history.  But the  increase  of urbanisation  and  industrialisation  and  the  rapid 
growth of  population have led both to greater numbers and concentrations of  pollutants 
and a greater number of people exposed to them.  As knowledge has grown about the 
impact  of pollution  on  health,  so  steps  have  been  taken  to  control  pollution  and 
improve hygiene  and  living  and  working  conditions,  for example by  supplying  clean 
water and installing sewage systems in towns. Indeed the improvements in the state of 
health  of Member  States'  populations  over the  last  200  years  owe  more  to  such 
measures than to advances in medical care and treatment. 
5.  Today in the European Community many of the diseases linked to poor environment 
and· hygiene  that  were  previously  rampant,  notably  infectious  diseases  arising  from 
polluted water, such as  cholera and  typhoid fever,  have been greatly reduced,  and in 
many cases virtually eliminated. Although a number of infectious diseases do remain as 
significant threats to health,  their place as the major 'health scourges' in  the Member 
States has been to a large extent filled by diseases which are caused by an interaction 
between environment, genetics and  life  style,  such as respiratory diseases and certain 
f01ms  of cancer.  Long-term exposure to relatively  low levels of pollution and  acute 
exposure to high  concentrations  may  play  a part  in  such  interactions,  and  different 
pollutants may intera,ct with each other. 
6.  Although pollutants contribute to the causation,  provocation or aggravation of these 
diseases, and are also associated with effects on health which might lead to subsequent 
disease,  the extent of their impact in  any  particular case will  depend  on  a range of 
factors,  such as genotype, age, occupation and !ifestyle of  the people concerned.  It is 
clear,  however,  that even where the contribution of a pollutant to the  causation or 
aggravation of any  specific disease is relatively  small,  the impact of the pollutant on 
public health may be consic!erable if  that disease is responsible for significant· morbidity 
and mortality. 
7.  Pollution contributes to many of the major causes of morbidity  and  mortality in the 
European  Community,  including  respiratory  problems,  allergies,  cancers,  cardio-
vascular  diseases  and  infectiou~ diseases,  neurological  disorders  and  immunological 
impairment. 
RESPIRATORY DISEASES 
8.  Over the last decades there has been a rise  in the prevalence of a number of serious 
respiratory diseases in the Community, such as asthma. 
Asthma 
9.  Bronchial asthma is a disease of the respiratory tract characterised by· unusually high 
sensitivity  of the  airways  to a wide  range  of stimuli  including  inhaled  irritants  and 
allergens. Asthma, may be either episodic or chronic, and in some cases may be fatal. 
10.  During the past few decades, there has apparently been a considerable increase in the 
prevalence  of asthma  in  the  European  Community  and  in  some  other  developed 
countries. This has created public concern about the disease and the possible causative -5-
factors involved. In the European Community the increase in death rate due to asthma 
was 27% between 1974-78 and 1980-84. In Finland the number of  people with asthma 
more than doubled between 1964 and  1987. By 1994 3% of its population had been 
diagnosed as asthmatics  .. Similarly,  in the Netherlands adult cases of asthma  doubled 
between 1972 and  1991. In the UK a parallel increase has been seen.  In  1994 asthma 
was  ·estimated  to  affect  4%  of  adults  sufficiently  severely  to  require  medical 
supervision.  The  trends  among  children  are  of especial  concern.  There  has  been  a 
doubling of  prevalence in young children during the 1970s and 1980s. Also in the UK, 
figures  for  1994  indicate  that  4-6%  of children  had  asthma  requiring  medical 
supervision.  It is  estimated that twice  as  many  have  had  a  diagnosis  of asthma.  In 
Denmark between 1987 and  1994 the prevalence of asthma has  increased from  3 to 
5%.  . 
11.  It has been suggested that part of  this reported increase in asthma may be the result of 
changes  and  improvements  in  diagnostic  criteria  and  techniques.  However,  recent 
studies,  which take into account these changes,  point strongly to the conclusion that 
there has been a real and continuing rise in cases of astqma.  Many factors have been 
put forward to explain this increase. 
12.  There  has  been  much  interest  in  outdoor air  pollution  as  a  possible  major  cause. 
Although levels of some pollutants have decreased greatly, the relative importance of 
emissions from traffic has increased at the same time as increases in asthma prevalence 
in  several· Member  States.  However,  the  importance  of the  outdoor  environment 
appears to be less significant than indoor air quality and lifestyle. There is a possibility, 
however, that there may be a link between some types· of. air pollution and the marked 
increase  in  the  prevalence  of early  onset  asthma  which  generally  occurs in  atopic 
individuals  i.e.  those  who  readily  form  IgE  antibodies  to  commonly  encountered 
allergens.  Changes  in  the  indoor  environment,  caused  by  changes  in  building 
construction,  such  as  the  increased  use  of central  heating  systems  and  insulation, 
(resulting in  a warm,  damp  indoor climate which  favours  the growth of house-dust 
mites and fungus) and in people's lifestyles leading them to spend more time indoors, 
are  deemed  to  be  of particular  importance  in  this  respect.  Smoking,  particularly 
maternal smoking, and diet are among other factors which may play a part. 
13..  Because of  the large numbers of  people within the European Community who are now 
affected by asthma,  factors which exacerbate the disease are potentially important in 
public  health  terms.  There  is  clear  evidence  of.effects of outdoor. air  pollution  on 
existing asthmatics.  Several  large-scale epidemiological studies analysing  changes in 
daily concentrations of  air pollutants have indicated that increases in concentration  are 
associated with substantial increases in hospital admissions for asthma increased visits 
to  paediatricians  and  emergency  departments  for  asthma,  and  increased  use  of 
medication by asthmatics. 
Chronic Obstructive Pulmonary Disease 
14.  Chronic Obstructive Pulmonary Disease (COPD), notably bronchitis and emphysema, is 
a significant cause of mortality and morbidity in the European Community.  In France, 
for example,  it  has been estimated that 2.5  million people are suffering from  chronic 
bronchitis,  one third  of them with chronic airway  obstruction.  Prevalence of COPD 
increases with age, and is currently higher for men than for women. Prevalence is also 
higher among smokers (and more women are now smoking),  among those with low 
social  status,  and  those  who  have  worked  in  occupations  where  there  are  high 
concentrations of airborne particles.  In Finland,  the prevalence in the elderly in  1994 
was estimated  at  12.5%  for  men  but was  less  for  women  at  3%.  With  respect  to 
mortality,  COPD  represents a major cause of death in  developed countries.  In some 
countries, the mortality rate has increased, for example in France the mortality rate rose -6-
between 1980 and  1991  from 26.7 per 100,000 to 29 per 100,000 for men and from 
12.3 to 17.0 for women. 
15.  It is,  however, difficult to determine with precision  the  prevalence of COPD  in the 
general  population,  because  the  diagnosis  of the  disease  is  usually  made  only  on 
hospital  patients  using  a  variety  of tests,  including  pulmonary  function.  It is  also 
difficult to compare prevalences between countries as different definitions are used and 
data are not always available. 
16.  With regard to causal factors for COPD,  as with astiur.a,  among known risk factors, 
some are genetic and others are related to behaviour.  Smoking certainly plays  a key 
role.  Air pollution is  known to  play  a part in  worsening these conditions.  The  first 
results of the  Community's  European APREA project  (Air Pollution and  Health:  a 
European  Approach)  indicate  that  an  increase  in  daily  concentrations  of some 
pollutants  has a detectable effect on both hospital admissions for COPD in European 
cities and on COPD mortality. But further work is  needed to determine the causative 
agents, and the relationships, temporal as well as spatial, between exposure levels to air 
pollutants and short and long term effects. 
ALLERGIES 
17.  Over the last  20  years,  there  has  been a  substantial  increase in  illness  perceived  as 
allergies throughout Europe, particularly in urban areas.  Since 1970 the prevalence of 
allergic  rhinitis  in  both adults  and  children has  doubled  in  a number of Community 
states, such as the UK and Sweden.  Current prevalence rates in the Community vary 
from 2 to 10%. 
18.  The response to foreign antigens is govemed by the immune system and is influenced 
by  a variety  of factors  including  genetic  predisposition,  dietary  habits,  lifestyle  and 
exposure to environmental  allergens.  It appears that although genetic factors  play a 
very important role, environmental pollutants are key factors in influencing the specific 
allergens  to which  ~  person  will  develop  hypersensitivity.  Among  these,  biological 
agents such as pollen, animal dander and house-dust mites are of  significance. 
19.  Pollen allergy is the most common form  of allergic disease.  150 years ago when hay 
fever  was  first  described,  it  was  a  rare  condition,  but  in  recent  years  it  has  been 
increasing  rapidly,  particularly  in  urban  areas.  Since  the  tum  of the  century,  a 
correlation between the level  of pollen and the extent of allergic  symptoms,  such  as 
conjunctivitis and rhinitis,  has been widely recognised. But since the level of pollen in 
the atmosphere has not increased,  the observed rise in allergies cannot be due to this 
factor alone. 
20.  The influence of  air pollutants is a factor that has to be taken into account as they may 
worsen the problem in three ways.  First they may increase the development of pollen 
allergy through a direct influence on the pollen grains to make them more allergenic. 
Second, there is  evidence that people react more strongly to allergenic substances if 
they have already been exposed to  certain outdoor air pollutants, such as particulates. 
Finally, exposure to pollutants in the urban atmosphere, such as suspended particulate 
matter  and  tobacco  smoke,  can  cause  a  general  increase  in  airway  reactivity  for 
example by assisting the pollen grains' penetration into the human body. 
21.  Indoor air pollution is also a factor to be considered. The main allergens in the indoor 
environment are the droppings of house-dust mites,  fungal  spores and  animal dander. 
House-dust mites,  which live  predominantly in and on mattresses and bedding and in 
floor  dust,  can provoke allergic  reactions and aggravate  existing  respiratory allergic -7-
symptoms. The prevalence of  sensitivity to these mites has been estimated to be almost 
30% in  certain  countries.  As  mentioned  earlier insulation  and  poor ventilation  may 
enhance the growth of  house-dust mites and fungi. 
OTHER DISEASES 
22.  A number of  other diseases are associated with pollution, including both cardiovascular 
diseases  and  cancer,  which  are  already  covered  by  Community  public  health 
programmes. 
23.  Cardiovascular diseases are the biggest cause of mortality in the Community. WHO 
has  estimated  that  1-2%  of cardiovascular  mortality  (in  people  with  pre-existing 
disease)  in  Europe  may  be  attributable  to  small  increases  in  fine  particulate  air 
pollution, and 3% or more in the most polluted areas.  An association has been found 
between the level of fine particles (less than 10 mm or less than 2.5 mm) polluting the 
air on a given day and the level of mortality in people with pre-existing cardiovascular 
or respiratory diseases. The physiological mechanisms involved are not yet clear, but it 
is  thought that  the  particulates  may  impair  pulmonary  function  and  produce  acute 
inflammatory reactions. 
24.  There is  evidence that other pollutants,  such as  environmental tobacco smoke (ETS) 
and carbon monoxide may also aggravate cardiovascular disease. 
25.  Cancer is second only to cardiovascular diseases as being the most important cause of · 
overall  death  in  the  European  Community.  Chemical  carcinogenesis,  that  is  the 
causation of  cancer by chemicals, has long been recognized in the occupational setting. 
The carcinogenic chemicals have for the most part, been the subject of  legislation, both 
at national and  at European Community level,  in order to reduce levels of exposure. 
The presence of even  low  levels  of carcinogens,  both naturally  occurring  and  man 
made, in the environment has raised concern about their possible effects on the general 
population.  There are a number of  factors that need to be given due consideration in 
the  aetiology  in  this  disease,  including  the  long  latency  period.  Studies  of thP 
geographical distribution of cancers give  some leads  as to the  possible  influence  of 
environmental factors in their causation.  However, it is considered that three quarters 
of cancer cases are linked to lifestyle,  and tobacco alone is responsible for a third of 
cancer mortality.  Although the major causal factor for lung cancer is  smoking,  non-
smokers also develop this disease.  Estimates vary, but it has been suggested that some 
9  - 13%  of cases  in  Europe have  been  associated with exposure  to  environmental 
tobacco smoke (ETS) i.e. passive smoking in the indoor environment. 
26.  A lot of attention by the general public has been given to the increase in  the use of 
electrical power in domestic and occupational environments, and in telecommunication 
and  broadcasting  devices  which  have  resulted  in  increased  levels  of exposure  to 
electromagnetic fields  (EMF)  and  radiation.  This  has  given  rise  to public  concern 
about  the  possible  consequences  for  health,  notably  whether  living  near  electrical 
power lines can cause childhood leukaemia or brain cancer.  However, there is no clear 
evidence of  an increased risk of  cancer from EMF.  A recent Commission report (Non-
ionising radiation: sources, exposures and health effects- CECN/1/LUX/35/95) found 
that existing epidemiological data are inconclusive and that biological studies have not 
so far demonstrated a plausible biological mechanism for EMF carcinogenesis. 
27.  Communicable  diseases  prevalence  is  in  many  cases  related  to  environmental 
pollution. Contamination of  drinking water and foods by microbiological agents can for 
instance lead to hepatitis A, typhoid fever,  cholera and  shigellosis,  and tuberculosis is 
related to poor living conditions.  Thus the improvements made in public hygiene and 
, 
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housing - proper waste disposal,  sanitation,  food  processing and  storage,  and  so  on, 
combined with vaccination and other medical interventions, have  greatly reduced the 
threat  from  many  of these  diseases  in  the  European  CommunitY.  However,  the 
incidence  of illness  related  to  food  contamination  in  particular  with  salmonella, 
campylobacter and listeria has increased in certain countries and is a cause for concern. 
28.  Auditory and non-auditory adverse health effects caused by  noise  is  an  issue  of 
growing importance.  Available European data indicate that noise levels in the urban 
environment are steadily increasing.  Important sources of background noise in urban 
areas are road traffic, railways,  aircraft, industry and construction work.  On the other 
hand changes in lifestyle such as the increasing use of  personal stereo systems  and the 
exposure to high sound levels (e.g. in discotheques) have been associated with impaired 
hearing.  Besides  hearing  impairment,  auditory  health  effects  include  possible 
impairment  of language  acquisition  and  cognitive  development  in  children.  The 
non-auditory health effects include stress, anxiety and sleep disturbance. -9-
Ill.  THE PREVENTION OF POLLUTION-RELATED DISEASES' 
29.  The prevention of pollution-related  diseases  has  three  elements. 'i First,  reducing  the 
amount of  pollutants by taking action at their source; second, acting to limit the amount 
of people's exposure to them;  and third,  mitigating the effec:ts  on individuals who are 
exposed to them.  Much work has  already been done both in  Member States and  at 
Community-level on the first two elements in controlling levels of  pollution in the fields 
of  air, water, food, waste and radiation protection; in researching into health effects and 
in limiting exposure to pollutants in occupational and domestic settings. 
30.  It is  not  feasible  or cost  effective  to  decrease  the levels· of all  pollutants,  or limit 
people's exposure to them, to the extent that they have no potential remaining to cause 
adverse effects on health.  In the case of naturally occurring potentially harmful agents 
,  in  the  environment,  such  as  UV light,  pollen  and  some  naturally  occurring  toxins, 
control of exposure is  most likely to be achieved by changes in individual behaviour. 
However, the possibilities of  synergism between air pollutants and pollen might make it 
possible to lessen the impact of pollen by controlling levels  of ambient  air  pollution. 
Furthermore,  controls on the levels  of pollutants adequate for  the  protection of the 
general  population  may  be  insufficient  to  prevent  adverse  effects  on  the  health  of 
certain vulnerable individuals  or groups in  the  population,  such  as  children  and  the 
elderly. 
31.  For these reasons  it  is  necessary  to  complement  the measures  aimed  at  controlling 
emissions of  and exposure to pollutants by public health actions relating directly to the 
general public.  These actions have as their goal the prevention of the development of 
diseases by limiting the exposure of  individuals and mitigating the related health effects. 
An example  of such  an  action  is  the  Directive  on  Ambient  Air  Quality:  Council 
Directive  96/62/EC  of 27  September  1996  on  ambient  air  quality  assessment  and 
management  (OJ No.  L  296  21.11.96,  p.  55-63).  The Directive  provides  for  limit 
values  to protect human  health,  but also  enables  thresholds to be  defined  at  which 
Member States would inform or warn the public of  poor air quality. 
32.  A prerequisite for undertaking such preventive actions effectively is having appropriate 
information  about  the  problems  to  be  tackled.  At  the  European  Community  level, 
current data do not provide a clear picture of the relationship between environmental 
pollution and disease, particularly as regards quantitative exposure-effect relationships. 
Although data on environmental  pollution have  been collected  for  a  long  period  at 
Community level and in the Member States, these data are primarily about levels and 
kinds of pollution.  Data on the effects of pollutants on health in the Member States, 
particularly  the  acute  effects  do  exist.  But  in  many  instances  the  precise  causal 
relationships involved have not yet been established. The  difficulties involved in doing 
so include problems in making accurate assessments of  exposure, particularly long-term 
exposure,  in establishing links between levels of exposure to pollutants of individuals 
or populations and longer term effects on health and the long latency periods between 
exposure to a pollutant and the development of clinical symptoms,  together with the 
presence  of confounding  factors.  Moreover,  relatively  little  data  exist  for  the 
Community as a whole, and this is an issue that needs to be addressed. -10-
IV.  OVERVIEW OF PUBLIC HEALTH ACTIONS IN THE MEMBER STATES 
AND INTERNATIONALLY CONCERNING POLLUTION-RELATED 
DISEASES 
Member States 
33.  The growing importance of  pollution-related diseases across the European Community, 
and  the increase  in  public  concern,  has  led  a  number  of Member  States  to  initiate 
preventive activities,  particularly in  relation to asthma and other respiratory diseases 
and to allergies. For example, in Denmark,· the Ministry of  Health produced an "Action 
Plan for a Strengthened Prevention of  Asthma and Allergy" in 1993, and the following 
year the French Ministry of  Health and,. the Comite Franyais d'Education pour la Sante 
launched  a  four-year  programme  aimed  at  raising  the awareness  of the  public  and 
health professionals about these diseases. 
34.  Specifically on asthma, Finland has established a ten-year programme which includes a 
range of measures aiming to increase information, improve early diagnosis, strengthen 
guided  self-care  and  decrease  atmospheric  irritants  which  provoke asthma,  such  as 
tobacco  smoke.  With  regard to  allergies,  in  1995  Sweden carried out a nationwide 
campaign 'Allergy year 95' which featured among other things a travelling exhibition, 
the 'allergy train' designed to spread information about the practical effects of allergies 
on people's lives,  promoted training of key groups,  such as teachers and parents and 
provided support for local projects. 
International Action 
3  5.  At  the  international  level,  the  WHO  organised  a  Second  European  Conference  on 
Environment  and  Health with  financial  support from  the  Commission.  A  report  on 
environmental  health  in  the  European  Region  entitled  "Concern  for  Europe's 
Tomorrow" was prepared for the Conference ,which was held in Helsinki in June 1994 
and  included  representatives  of 4  7  of  the  WHOIEURO  Member  States.  The 
representatives endorsed the Environmental Health Action Plan for Europe, a strategy 
to prevent and  control  environmental  health hazards,  and adopted a Declaration on 
Action for Environment and Health in Europe.  Under this the participating countries 
committeq their respective health and  environment departments to developing jointly 
national  environmental  health  action plans  by  the end  of 1997.  Italy and  the United 
Kingdom are two of the six countries participating in  a Pilot Project to develop their 
action plans by 1996 and to share their experiences with other countries. 
36.  The Conference also  established a European Environment  and Health Committee to 
support  the development of  National Environmental Health Action Plans and to assist 
in  the  coordination  and  evaluation  of the  implementation  of Environmental  Health 
Action Plan for Europe. The Commission is represented on this committee so  helping 
to ensure that these activities complement rather than overlap Community action. ;-11-
V.  OVERVIEW OF COMMUNITY ACTIONS RELEVANT TO POLLUTION-
RELATED DISEASES 
Environment Policy 
37.  Many  measures  to  control  pollution  and  exposure  levels  are  being  taken  in  the 
framework of  the Fifth Community Action Programme for the Environment "Towards 
Sustainability" (OJ No. C 138, 17.5.93). Among its priorities are "the improvement of 
public health and safety" and the integration of  environmental concerns into all aspects 
of Community  policy  and  decision  making.  This  programme  builds  upon  the  large 
volume of existing Community legislation on air,  water and  soil  pollution,  chemicals, 
waste disposal and protection from radioactivity. 
38.  A  Framework  Air  Quality  Directive  has  recently  been  adopted  (Council  Directive 
96/62/EC on  ambient  air  quality  assessment  and  management  (OJ  L  296  21.11.96, 
p.55-63).  Within  the  context  of this  Framework  Directive,  the  Commission  is 
developing  or  revising  legislation  on  ambient  air  quality  standards  for  the  major 
atmospheric  pollutants  taking  into  account  the  impact  on  human  health  and  the 
envjronment. Pertinent proposals will also include provisions for the dissemination of 
information to the public. 
39.  New initiatives are being taken in  sev§ral  areas,  such  as  controlling  emissions  from 
motor vehicles,  revising  existing  directives  on  bathing  and  drinking  water  quality, 
providing public information about the effects of radiation on health and drawing up a 
strategy to reduce the risks from chemical products.  On the other hand,  work under 
the directive  on the classification  and  labelling  of both new and  existing  dangerous 
chemical substances (OJ L 133, 30.5.88), and under the directive on the classification 
and  labelling of dangerous chemical  preparations  (OJ L  187,  16.7.88,  p.14)  is  on-
going. These directives contain the criteria that need to be fulfilled for chemicals to be 
classified  on the basis of their e.g.  dermal  toxicity  and  by  the inhalation route,  skin 
sensitization,  skin and eye irritation.  Such criteria can be updated on the basis of the 
latest scientific evidence. 
40.  The  European  Environment  Agency  was  established  to  provide  policy  makers  at 
European and national level  with environmental information that is  objective, reliable 
and  comparable.  The  Agency,  working  closely  with  national  authorities  and  the 
Commission,  is compiling information on air and water pollution, with details  of the 
pollution sources that will be a useful input to the field of pollution-related diseases. It 
is  collaborating with the WHO  and  has  produced a first  report on Environment  and 
Health. The Agency plans to undertake further studies in this area. 
41.  Commission services and  the European Environment  Agency  have  recently compiled 
extensive  information  concerning  both  current  and  future  air  quality.  In  addition, 
initiatives to reduce anthropogenic emissions of atmospheric pollutants are already in 
place  or being  developed  via  a  number  of Community  initiatives  e.g.  the  Auto  Oil 
Programme and the resulting legislation on vehicle emissions (OJ No.  L 100,  19.4.94, 
p. A2), the Directive on Integrated Pollution Prevention and  Control (OJ No.  C 87, 
25.3.96,  p.  8),  and  the Directive on the  control  of Emission from  Non-road Mobile 
Machinery (OJ No. C 328, 7.12.95, p.1). -12-
Actions In Other Policy Areas 
42.  Relevant  Community  activities  are  also  being  undertaken within  other policy  areas. 
Within the foods  policy framework,  three directives were adopted by the Council in 
1995  on maximu~ residue levels for a number of active substances in  pesticides.  In 
health and safety at work there is an extensive body of  up-to-date legislation to protect  ' 
the  worker,  including  directives  on  the  physical,  chemical  and  biological  agents  at 
work.  Activities  are  on-going,  including  work  on  occupational  exposure  limits  for 
chemical  substances  (including  broadening  the  existing  directive  on  occupational 
exposure to  carcinogens),  and  in  developing  the. Safety  Action for  Europe (SAFE) 
programme which aims at improving safety, hygiene and health at work, particularly in 
small and medium-sized enterprises. 
43.  In 1995 the Commission also presented a Green Paper for a European Union  Energy 
Policy ( COM (94) 659 final  11.1.1995) which inter alia covers public health issues and 
makes  proposals  for  the  support  of new  clean  technologies .to  reduce  emission  of 
pollutants.  Finally,  within  the  framework  of  the  Community  Research  and 
Technological·Development Programme,  relevant  research projects are being  carried 
out in  the programmes on Environment  and  Climate,  Agriculture and  Fisheries,  and 
Biomedicine  and  Health.  In  the  Community's  Fourth  Framework  Programme  for 
research  and  technological  development  (Decision  94/1110/EC  of 26.04.1994,  OJ 
L126,  18.05.94,  p.1,  as  amended  by Decision  96/616/EC  of 25.03.1996,  OJ  L86, 
04.04.96,  p.  69),  namely the Biomedicine and Health Programme, the research under 
the  area  of "Chronic  diseases,  Ageing  and  Age-related  diseases"  is  conducted  on 
aetiology,  including  environmental  aspects,  and  treatment  and  management  of 
respiratory problems including asthma. Research objectives under the research area of 
"Occupational and Environmental Health" cover identification of  important risk factors 
and  their  control  also  related  to  respiratory  problems  and  allergies  of public  and 
occupational health importance. 
Council 
44.  In its Resolution of 11  November 1991  (OJ C304 23.11.91, p.  6) the Council and the 
Ministers  for  Health,  meeting  within  the  Council,  inVited  the  Commission;  in  close 
cooperation with the competent authorities of  the Member States to take stock of the 
knowledge  and  experience  available  in  the  Member  States,  the  Community  and 
international  organizations  regarding  the  relationship  between  health  and  the 
environment.  · 
European Parliament 
45.  In its Resolution A4-0311/95  (OJ C 032  05.02.96,  p.15-24)  on the  Medium-Term 
Social Action Programme 1995-1997 the Parliament asked the Commission to present, 
under  the  proper  procedures,  the  action  programme  foreseen  in  the  Commission's 
framework communication on public health for pollution-related diseases as well as the 
other two programmes foreseen, on rare diseases and on accidents and'injuries. 
Economic and Social Committee 
46.  In  recent  years  the  Committee  has  delivered  a  number  of Opinions  relating  to 
environmental pollution and to health.  In its wide-ranging Opinion of 6 July  1994  on 
the Comn:1ission's framework communication on public health it urged the Commission 
to  adopt  a  broad  approach  to  the  subject  and  emphasised  the· importance  of the 
environment for health promotion.  ' -13-
VI.  APPROACH TO COMMUNITY PUBLIC HEALTH ACTION ON 
POLLUTION-RELATED DISEASES 
4  7.  Future Community public health action on pollution-related diseases must take account 
of  the existing large body of work in particular that undertaken under Articles 129 and 
130r of  the E.C. treaty.  In accordance with Article 129 of  the Treaty the Community 
shall  contribute  towards  ensuring  a  ·high  level  of human  health  protection  by 
encouraging cooperation between Member States, lending support to their actions and 
promoting, in close contact with them, coordination of  their policies and programmes, 
and  fostering  cooperation  with  third  countries  and  international  organisations 
competent in the sphere of  public health. 
48.  According to the principle of  subsidiarity, the Community shall take action in this field 
only if  and in  so far as,  by reason of its scale or effects the proposed action can be 
better· achieved by the Community,  compared to action at national level.  In addition 
action  by  the  Community  must  be  proportional  to  the  objectives  to  be  achieved, 
selected on the basis of  prior appraisal and expected to yield added value. 
49.  With the limited  resources available it would be impractical for a Community public 
health programme to address all the numerous pollution-related diseases. Moreover, to 
try to do so would both reduce the effectiveness of such a programme by making the 
actions too diffuse and  also increase the risk of straying into areas covered by  other 
Community programmes. 
50.  In  order  to  select  which  pollution-related  diseases  should  be  priorities  for  this 
programme  a  number  of selection  criteria  have  to  be  considered,  based  on  the 
methodology for setting priorities described in Commission communication COM (93) 
559 on the framework for action in the field of  public health. These are that 
public health actions relating to the disease are not being undertaken as part 
of  other Community programmes; 
there is evidence that current levels of  exposure to pollutants represent a health 
risk and furthermore there is considerable population exposure; 
the disease produces a substantial burden of morbidity and/or mortality in the 
Community and/or there is  evidence of its prevalence increasing  significantly; 
and 
actions by the Community add value compared to the activities of  the Member 
States. 
51.  In the light of these criteria this  programme will  place the central  focus  on diseases  . 
related to air  pollution,  primarily  respiratory  diseases  and  allergies.  Currently  in  the 
European Community, the highest exposure levels of the population to  pollutants are 
to at111ospheric pollutants. Moreover, despite a reduction in the concentration of some 
air pollutants,  recent  evidence  shows that there are  still  important effects associated 
with  pollution  at  concentrations  now  present  in  the  European  Community.  These 
effects may be associated with short term changes in  concentrations of pollution and 
there is emerging evidence of  effects from long-term exposure. The resulting morbidity 
and mortality are giving rise to public concern. 
52.  Second,  preventive  actions  on  several  of the  other  categories  of pollution-related 
disease are already being taken within the framework of  the Community's public health 
strategy. Actions in relation to cancer fall within the scope of  the Europe against cancer 
programme;  prevention of cardio-vascular diseases  is  covered  in  the  programme  on 
health promotion;  and actions on communicable; diseases are being undertaken under 
the programme on AIDS and certain other communicable diseases. .  -14-
53.  As regards diseases related to noise, effective prevention ha$ to be focused on actions 
to reduce  emissions  and  exposure  levels.  Community-wide  requirements  regarding 
occupational exposure to noise have been laid  down in  directive 86/188/EEC (OJ L 
137 24.05.86, p.28) and proposals for amending provisions have been put forward by 
the Commission. 
54.  There are several Community initiatives  addressing the various issues and aspects of 
air pollution e.g. THERMIE  II (COM (94) 654 final),  C02 from cars strategy paper 
(COM(95) 689 final),  and the Green paper on Fair and Efficient Pricing in Transport 
policy - options for internalizing the external  cost of transport in the EU (COM(95) 
691 final) 
55.  Respiratory diseases and allergies, on the other hand, are not within the ambit of  other 
public health programmes.  They also  offer significant  opportunities for  action to be 
taken by the Community which can complement both the existing Community work on 
control of  pollution in the environment ·and the activities of  the Member States. Action 
on these diseases will therefore constitute the core of  a programme on pollution-related 
diseases which is the object of a proposal by the Commission pursuant to Article 129, 
for a decision by the European Parliament and the Council. -15- • 
Vll.  COMMUNITY ACTION PROGRAMME ON POLLUTION-RELATED 
DISEASES 
56.  In order to make the best possible contribution to efforts directed at pollution-related 
diseases, the proposed Community action programme contains a mix of  horizontal, and 
disease-specific  actions  focusing  on  respiratory  diseases  and  allergies.  Several/ 
horizontal  actions  aiming  at  the  improvement  and  sharing  of information  and 
experience on risk perception and  risk management  of pollution-related diseases  are 
proposed  which .will  help  underpin the actions  directed  at  specific  pollution-related 
diseases.  There is a need to ensure complementarity between the information collected 
by this programme and other Community programmes. or activities whiqh are relevant 
to this area of  public health. 
1.  Improvement of  Information on pollution-related diseases at Community Level 
57.  Data on pollution-related diseases exist but at present are insufficient and inadequate at 
Community  level  for  use,  in  particular,  in  decision-making  or for  the  provision  of 
information to the public about risks to health. In large part this is because the data are 
not detailed enough or suitable for the purpose of understanding causation, thresholds 
for effects and exposure-response relationships or synergisms; also data are often not 
comparable.  In  connection  with  respiratory  diseases,  in  particular,  there  are 
considerable variations in diagnostic criteria and classification of  the different diseases. 
58.  What is needed is to work towards critically reviewing the data and  then to improve 
their comparability.  This  will  involve  for  instance  seeking  agreement  on  diagnostic 
criteria and  surveillance  methods  and  establishing  comparable  indicators.  This  latter 
task  must  be  undertaken  in  tandem  with  the  proposed  Community  programme  on 
health  monitoring  (COM(95)449  of  16.1 0.1995).  It  will  require  strengthening 
cooperation  between  those  involved  in  the  collection  and  analysis  of the  data 
concerning  pollution-related  diseases  and  improving  the  existing  mechanisms  for 
exchanging  data  between the  Member  States.  It will  be  necessary  to  check  that 
pollution  data  are available  to  support  health  effect  analysis.  Long-term  data  abot.. 
pollution should be sought in addition to data about short-term peaks. 
59.  The objective of  Community action is 
to contribute towards a better understanding of  the role of pollutants in the 
causation and aggravation of diseases in the European Community and  of the 
basis and effectiveness of  preventive actions. 
60.  The actions to be taken to achieve this objective could include: 
Establishing priorities for the identification of  those diseases in which specific 
pollutants  are  thought  to  play  a  role;  comparing  their  prevalence  and/or 
incidence  and  their relation to  data on environmental  factors  in  the  different 
parts of the European Community;  examining the data quality and  identifying 
where data are lacking; analysing and reviewing data currently available on the 
toxicology of these pollutants,  and  identifying  gaps in  knowledge;  comparing 
these data,  including methods of collections,  definitions  and  criteria used,  as 
well as the way in which the information is used in analyses, in determining the 
actions taken and in informing the public. 
Contributing to improve the comparability of  data used in preventive actions by 
the support of  exchanges of information on pollution-related diseases and their 
prevention, including cost-benefit analysis ofthe effectiveness of  actions. -16-
2. Risk Perception and Risk Management with respect to pollution-related diseases 
61.  The public perception of the risks to health from pollution, especially their magnitude 
and their ranking in  terms of importance from  the health point of view,  often differ 
considerably  from  an  expert  assessment, ·and . this  can  lead  to  unnecessary  public 
concern and pressure for  disproportionate actions to be taken  . 
.  ,  l 
62.  Experience  shows  that  there  are  several · reasons  for ·this.  First,  people  are  better 
informed  and  made much  more  aware of risks  by information provided through the 
media.  Second, the expectation that th~re sho.uld be zero risk to health is an ideal that 
is rarely achieved, if  ever, in practice.  Third, there is frequently a lack of  understanding 
of how  pollution-related  risks  are  assessed  and . the  principles  adopted  for  their 
management  and  of the  scope  of some  of the  terminology,  such  as  "negligible", 
"tolerable" or "acceptable" levels of  risk, as used in national and Community prevention 
and control measures. 
63.  Fourth,  misunderstandings  can  arise  because  of a  lack  of information  about  the 
proportion of  the risk to health attributable to pollutants compared with other factors, 
such as lifestyle,  and  because of the ways in which the media sometimes present the 
information.  The tendency  of the  public  to underrate the contribution  of smoking, 
including environmental tobacco smoke,  compared with that of ambient air pollutants 
to the causation of respiratory and  cardiovascular diseases illustrates this  point.  The 
public  concern  about  possible  risks  from  Electromagnetic  Fields  (EMF)  provides · 
another example of  the disparity between experts and public opinion. 
64.  Fifth, in general the public perceives risk differently than what is suggested by scientific 
evidence. . This might mean that factors that lead to certain lesser risks are given much 
greater importance compared to others.  This i$ in part due to the acceptance of  risk as 
a result of the degree of personal control that can be exercised over the sources of 
risks. 
65.  In this light the objective of  Community actions is: 
to increase the level  of knowledge and  understanding about pollution-related 
health risks, their perception, assessment and management. 
66.  The actions to be taken to achieve this objective could include: 
Supporting acti~ns aimed at achieving better public understanding of  risks, their 
assessment  and  management;  promoting work on the  public  perceptions  of 
pollution-related risks to health throughout the Community. 
Promoting actions and exchanges of information on the methods of increasing 
the level  of knowledge  of the  general  public  and  opinion-formers  about  the 
assessment of  pollution-related risks to health. 
3. Respiratory diseases and allergies 
67.  The increase in the prevalence of respiratory diseases and  allergies in  recent decades 
has created increasing burdens on society in general, added pressure on health services, 
and led to considerable public concern.  · -17-
68.  The objective of  Community actions in this area is 
to support activities aimed at reducing the  prevalence and/or incidence of  these 
diseases. 
69.  The actions to be taken  to achieve this objective could include 
Contributing  to  the  provision  of information  to  the  general  public  and  to 
specific  groups,  on  these  diseases  and  the  agents  that  play  a  role_ in.  them; 
supporting  the  development  of ways  to  reinforce  and  link  iriformation 
campaigns; contributing to the efforts of self-help  or support groups active in 
the field of  respiratory diseases and allergies. 
Contributing to the  comparison  of various  education  and  training  initiatives 
used · to  combat  these  diseases,  with  a  view  to  promoting  best  practice; 
reviewing  the  effectiveness  of the preventive  measures  undertaken,  including 
cost/benefit analyses. -18-
VITI. CONSULTATION, ASS£SSMENT AND REPORTS 
Consultation 
70.  The actions  of this  programme will  be implemented  in  close  collaboration with  the 
Member  States,  particularly  in  so  far  as  regards  coordination of their  policies  and 
programmes. To facilitate this, the Commission proposes the creation of an Advisory 
Committee of representatives ·of the Member  States.  Appropriate links  will  also  be 
maintained  with  the  European  Environment  Agency,  the  WHO,  other  relevant 
international organisations and third countries in accordance with the requirements of 
the programme's actions.  · 
Evaluation reports 
71.  Assessment ofthe programme will be provided in  two reports: 
an evaluation report during the third year of  this programme to the Council, the 
European Parliament, the Economic and Social Committee, and the Committee 
of the Regions.  The purpose of this report is  to ensure that the Community 
institutions and, through them, all the parties concerned, are kept fully informed 
on the progress of  actions undertaken in the context of  this programme. 
a final  report on the implementation of the programme, which will include an 
evaluation of  the actions undertaken, will be submitted to the above mentioned  · 
institutions by the Commission after .the completion of  the programme. 
General information activities 
72.  The  Commission  will  ensure  that  reports  qn  the  activities  undertaken  are  made 
available to concerned parties and the general public. '  ! 
Proposal for a 
EUROPEAN PARLIAMENT AND COUNCIL DECISION 
adopting a programme of  Community action 1999-2003 on pollution-related diseases in the 
context of  the framework for action in the field of  public health EXPLANATORY MEMORANDUM 
1.  In its Communication (COM(93) 559 final)  of 24 November 1993  on the framework 
for  action in  the field  of public  health,  the Commission  outlined  the  principles  and 
strategy  to be  followed  in  undertaking  Collllllunj.ty  activities  directed  towards  the 
attainment of  the objectives on health protection laid down in Articles 3(o) and 129 of 
the  Treaty  establishing  the  European  Community.  The  role  of the  Community  is 
identified as underpinning the efforts of the Member States in the public health field, 
assisting  in  the  formulation  and  implementation  of objectives  and  strategies,  and 
contributing to the provision of  health protection across the Community, setting as the 
target the best results already obtained in a given area anywhere in the Community. 
2.  In accordance with Article 129, the Commission presents proposals for the adoption by 
the European Parliament and the Council of incentive measures intended to contribute 
towards  ensuring  a  high-level  of human  health  protection.  The  aforementioned 
Commission's communication sets out criteria on which to determine priority areas for 
Community  action  programmes. In accordance  with these  criteria,  pollution-related 
diseases were identified as such a priority area.  · 
3.  ·The present Commission proposal, based on Article 129 and already announced in the 
Commission  programme  of work  for  1996,  comes  under  the  principle  of shared 
competence between the Community and the Member States,  and  seeks to improve 
information  on  and  prevention  of pollution-related  diseases  especially  respiratory 
diseases and allergies, and increase the level of  knowledge and understanding about risk 
perception,  and  risk  assessment  aild  management with respect to these,  in  order to 
contribute  towards  ensuring  a.  high-level  of  protection  against  pollution-related 
diseases. Community action in this field does not come under the exclusive competence 
of  the Community and is geared towards the prevention of pollution-related diseases. 
According to the principle of  subsidiarity, Community action shall be undertaken only if 
and  in  so  far  as,  by  reason  of its  scale  or effects,  it  may  be  better  achieved  at 
Community level. 
4.  Pollution-related diseases are those diseases which are caused, provoked or aggravated 
by environmental pollution.  These diseases,  particularly those linked to air pollution, 
both indoor and outdoor, constitute an  important and growing part of morbidity and 
mortality in the European Community, and they are the object of considerable public 
concern. 
5.  The prevention of pollution-related  disease pre-supposes knowledge  of relationships 
between pollutants and diseases, and has three subsequent elements. First, reducing the 
emission  of pollutants  by  taking  action  at  their  source;  second,  acting  to  limit 
concentrations of pollutants and exposure to them; and third,  qlitigating the effects on 
individuals  who  are  exposed  to  them.  Much  work  has  already  been  done  both  in 
Member States and at Community-level in controlling levels of pollution in air, water, 
soil,  food  and  waste,  in  researching  into  its  effects  and  in  limiting  exposure  to . 
pollutants. 
6.  The proposed  5-year  action  programme  seeks to complement  this  work by  actions 
addressed to the public, health professionals, and the authorities, which aim to enhance 
people's ability to reduce exposure and mitigate the effects of  pollution. on their health. 
7.  With the limited  resources available it would be impractical for a Community public 
health  programme  to  address  all  the  numerous  pollution-related  diseases.  This 
programme will  therefore  place  its  central  focus  on  diseases  related  to  indoor  and 8. 
9. 
·-2.} 
outdoor air pollution, primarily respiratory diseases, and on allergies.  In the context of 
this  programme  indoor  air  relates  to  non-occupational  environments,  where  less  is 
known at Community· level  about the  nature and  extent of exposures.  Currently the 
highest exposure levels of  the Community population to pollutants are to atmospheric 
pollutants, and this exposure is creating a significant risk to health.  The prevalence of 
pollution-related  diseases  is  continuing  to  rise  with  accompanying  public  concern. 
Finally,  these  diseases  offer  significant  opportunities  for  action  to be taken by  the 
Community which can complement both its existing work on control of  pollution in the 
environment and the activities of  the Member States. 
To underpin these actions, it is also proposed to undertake; in close cooperation with 
the  Member  States,  actions  in  two  general  fields.  The  first  is  aimed  at  improving 
information  on  pollution-related  diseases  at  Community  level.  This  is  currently 
inadequate, particularly because Member States' .data are often not comparable. Action 
to  improve  this  situation  is  proposed  to  be  undertaken,  complementary  to  that 
proposed under the future heatth monitoring programme (amended proposal COM(96) 
222 final). The second set of  actions is aimed at addressing the problems that arise from 
people's  perception of the risks  to health from  pollutants  and  how these  risks  are 
assessed  and  managed,  as  well  as  from  the  lack of adequate  information  on  such 
perceptions. 
In selecting objectives and defining actions to be included in the programme, account 
has  been  taken  of the  situation  currently  existing  in  the .Member  States  and  at 
Community  level  in  the  field  covered  by  the  programme.  The  programme  aims  at 
bringing  about  an  accelerated  and  effective  sharing  of information  and  experience, 
Community  wide  understanding  of key  issues  and  questions  on tackling  pollution-
related  diseases,  and  increased  cooperation  of Member  States  so  as  to  avoid 
unnecessary  duplication  of work  and  speed  up  the  adoption  of best  solution  to 
problems common to all the Member States concerning such diseases. 
10.  These problems have be.en the object of resolutions by the Council and the Ministers 
for Health of  the Member States meeting within the Council on 11.11  1991  (OJ No C 
304, 23.11.91, p.  6) as well as by the European Parliament A4-0311/95 (OJ No C 032 
05.02.96, p.  15-24) calling for Commission proposals in the area. 
11. 
I 
The implementation of  the programme will yield added value in a number of  ways: 
a)  It will bring together the Member States in a common effort to critically review 
and improve methods for collecting and using information on pollution-related 
diseases and its content, extent and quality;  · 
b)  It will improve the collective capacity of the Member States to analyze public 
perceptions of pollution-related risks and better explain how they are assessed 
and  managed,  especially  when  contributors  to pollution  in  a  given  Member 
State have their origin or source in other Member States; 
c)  It will accelerate and deepen the process of  addressing the increased prevalence 
and  concern  over  respiratory  diseases  and  allergies  by  promoting  focused 
cooperation between the Member States in this area. 
12.  This  programme  is  undertaken  on the basis  of a  European  Parliam~nt and  Council 
decision  pursuant  to  Article  129.  It does  not  require  the  harmonisation  of national 
provisions in the field covered. 
13.  An evaluation of the actions implemented under. this programme will  be  provided  in 
two  reports that  will  be  transmitted  to  the  Council,  the  European  Parliament,  the 
Economic and Social Committee, and the Committee of  the Regions: 
- during the third year of  the programme, an evaluation report; 
; 
! 
: - a final report on the implementation of  the programme. 
These  reports will  incorporate information  on  Community  financing  in  the  various 
fields of  action as well as the results of  evaluations. 
~~  ~ --- -~~--- -----~- -~-2.3 
Proposal for a 
EUROPEAN PARLIAMENT AND COUNCIL DECISION 
adopting a programme of Community action 1999 - 2003 on pollution-related diseases 
in the context of  the framework for action in the field of public health 
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION 
Having regard to the Treaty establishing the European Community,  and in particular Article 
I29 thereof, 
Having regard to the proposal from the Commission, 
Having regard to the opinion of  the Economic and Social Committee, 
Having regard to the opinion of  the Committee of  the Regions, 
Acting in accordance with the procedure referred to in Article I89b of  the Treaty, · 
I.  Whereas  pollution-related  diseases  are growing in  importance throughout  the European 
Community and raising public concern;  .  ·  .  · : 
2. Whereas, in accordance with point (  o) of Article 3 of  the Treaty, Community action shall 
include a contribution to the attainment of  a high level of  health protection; 
3.  Whereas  Article  129  expre~sly provides  for  Community  competence  in  this  field,  by 
encouraging  cooperation between the Member States and,  if necessary,  lending  support t_ 
their  action;  promoting  coordination  of their  policies  and  programmes,  and  fostering 
cooperation with third countries and international organisations competent in the sphere of 
public  health;  whereas  Community  action  should  be  directed  towards  the  prevention  of 
diseases, and the promotion of  health education and information; 
4.  Whereas _Article  130r of  the Treaty states that Community policy on the environment shall 
contribute to protecting public health; 
5. Whereas the prevention of  pollution-related diseases has to include not only measures aimed 
at the sources and concentrations of  pollutants and on limiting exposure, but also public health 
actions directed at the public to enable individuals to reduce exposure and mitigate adverse 
effects on health and whereas data on health effects and on exposure should be collected in 
parallel with data on concentrations of  air pollutants; 
6.  Whereas in its Resolution of11 November I99I
1
. the Council and the Ministers for Health 
of the  Member  States,  meeting  within  the  Council,  invited  the  Commission,  in  close 
cooperation  with  the  competent  authorities  of the  Member  States,  to  take  stock  of the 
knowledge and experience available in  the Member States, the Community and international 
organizations regarding the relationship between health and the environment; 
I  OJ N° C 304  23.11.91, p.  5 7.  Whereas pollution-related diseases  have been identified ·as  a priority area for  Community 
action within the framework for action in the field of  public health
2 ~ 
8.  Whereas in its Resolution (A4-0311/95) on the Medium-Term Social Action Programme 
1995-1997
3 the Parliament asked the Commission to present, under the proper procedures, the 
action  programme .on  pollution-related  diseases  foreseen  in  the  Commission's  framework 
communication on public health~ 
9  ~  Whereas, in accordance with the principle of subsidiarity,  action on matters not under the 
exclusive competence of  the Community, such as action on pollution-related diseases, must be 
undertaken by the Community only if and in so far as,  by reason of  its scale or effects, it may 
be better achieved at Community level~ 
10.  Whereas the proposed measures in the present programme will  yi~ld a Community-added 
value by bringing together activities already undertaken in  relative isolation at national level 
and by complementing one another with significant results for the Community as a whole, by 
contributing to the strenghtening of  solidarity and cohesion in the Community and by leading, 
where the need is recognised, to the establishment of  best practice norms and standards. 
11.  Whereas ·cooperation with the international organisations competent in the field  of public 
health and with third countries should be fostered~ 
12.  Whereas, by providing support for acquiring better knowledge and understanding of,  and 
wider dissemination  of information  about,  pollution-related  diseases,  their association  with 
pollutants  and  their  prevention,  ensuring  improved  comparability  of information  on  these 
subjects and  by developing actions complementary to existing Community programmes  and 
actions,  while  avoiding  unnecessary  duplication,  the  programme  will  contribute  to  the 
achievement of  the Community objectives set out in Article  129~ 
13.  Whereas  a  "modus  vivendi"  betWeen  the  European  Parliament,  the  Council  and  the 
Commission concerning the implementing measures for acts adopted in  accordance with the 
procedure laid down in Article 189b of  the Treaty was concluded on 20 December 1994~ 
; 
14. Whereas this decision lays down, a financial framework constituting the principal point of 
reference, within the meaning of point  1 of the Declaration of the European Parliament,  the 
Council and the Commission of 6 March 1995, for the budgetary authority during the annual 
budgetary procedure; 
15. Whereas the Community's financial perspective is valid up until  1999 and will have to be 
revised for the period beyond that date~ 
· 16.  Whereas the financial  framework for the last four years of the programme (2000-2003) 
shall be determined after the establishment of  the future financial  perspectives~ 
17.  Whereas,  in  order to  increase  the  value  and  impact  of the  programme,  a  continuous 
assessment of the actions  undertaken  should be· carried out,  with particular regard  to  their 
effectiveness and the achievement of  the objectives set and, with a view where appropriate, to 
making the necessary adjustments;  .  .  · 
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18.  Whereas this programme should be of  five-year duration in order to allow sufficient time 
for actions to be implemented to achieve the objectives set;  · 
HAVE DECIDED AS FOLLOWS: 
Article 1 
Establishment of the programme 
1.  A  prograi)Ulle  of Community  action  agaiJ1st  diseases  which  are  caused,  provoked  or 
aggravated by environmental pollution, hereinafter referred to as "this programme", is hereby 
adopted for the period 1 January 1999 to 31  December 2003 in the context of the framework 
for action in the field of  public health. · 
2.  The aim  of this  programme  is  to  contribute  towards  ensuring  a  high  level  of health  . 
protection against pollution-related diseases by improving knowledge and understanding about 
health risks associated with them and how to address them, in particular with regard to asthma 
and other respiratory diseases, and to allergies. 
3.  The actions to be implemented under this programme and  their specific objectives· are set 
out in the Annex under the headings: 
1.  Actions on improvement of  information on pollution-related diseases 
2.  Risk perception and risk management with respect to pollution-related diseases 
3.  Respiratory diseases and allergies  - ·  ·  . ; 
Article 2 
Implementation 
1. The Commission shall ensure implementation, in close cooperation with the Member States, 
of  the actions set out in the Annex. 
2.  The Commission shall  cooperate with institutions and organisations active in  the field  of 
pollution-related diseases.  · 
Article 3 
Budget 
1. The financial framework for the implementation ofthe programme for the year 1999 shall be 
ECU 1.3  Million,  in keeping with current financial perspectives.  The financial framework for 
the final  four years of the programme  (2000-2003)  shall  be  determined  in  detail  after the 
establishment of  the future financial perspectives. 
2.  The annual  appropriations shall  be established by the Budgetary Authority in  accordance 
with the financial perspectives. Article 4 
Consistency and complementarity 
The  Commission  shall  ensure  that there  is  consistency  and  complementarity  between  the 
Community actions to be implemented under this programme and those implemented under 
other relevant Community programmes and actions.  · 
Article 5 
Committee 
1.  In  implementing  this  action  plan,  the  Commission  shall  be  assisted  by  an  advisory 
committee,  hereinafter referred  to as  "the  Committee",  consisting of representatives  of the 
Member States and chaired by the Commission representative. 
2. The representative of  the Commission shall submit to the Committee a draft of  the measures 
to be taken conc"!rning, in particular: 
(a)  the criteria, and procedures for selecting and financing projects under this programme; 
(b)  the evaluation procedure. 
The Committee shall deliver its opinion on the draft, within a time limit which the chairperson 
may lay down according to the urgency of  the matter, if  necessary by taking a vote. 
The opinion shall be recorded in the minutes;  in  addition,  each Member State shall have the 
right to ask to have its position recorded in the minutes. 
The Commission shall take the utmost account of  the opinion delivered by the Committee. It 
shall inform the Committee on the manner in which its opinion has been taken into account. 
3. The representative ofthe Commission shall keep the Committee regularly informed about  · 
Commission proposals or Community initiatives  and the' implementation of programmes in 
other policy areas which are relevant to the achievement of  the objectives of  this programme. 
Article 6 
International cooperation 
1.  In the course of implementing this programme, cooperation with third countries and with 
international organisations competent in the field of  public health shall be fostered. l 
2.  This  programme  shall  be  open  to  participation  by the  associated  countries  of Central 
Europe (CEC), in accordance with the conditions laid down in the Association Agreements or 
Additional Protocols  related thereto concerning participation in Community programmes. This 
programme  shall  be open to participation by  Cyprus  and  Malta on the basis  of additional 
appropriations in accordance with the same rules as those applied to the EFT  A countries, in 
accordance with procedures to be agreed with those countries. 
Article 7 
Monitoring and evaluation 
1. In the implementation of  this Decision the Commission shall take the necessary measures to 
ensure the monitoring and  continuous evaluation of the programme,  taking account of the 
general and specific objectives referred to in Article 1 and in the Annex. 
2.  In the third  year of operation of this  programme,  the  Commission  shall  present  to  the 
European Parliament and the Council an evaluation report. 
3. The Commission shall submit to the European Parliament and the Council a final  report on 
completion of  this programme. 
4.  The  Commission  shall  incorporate  into  these  two  reports  information  on  Community 
financing in the various fields of  action and on complementarity with the other actions referred 
to in Article 4, as well as the results of  the evaluations. The reports shall also be submitted to 
the Economic and Social Committee and the Committee of  the Regions. 
Done at Brussels, 
For the European Parliament 
The President 
For the Council 
The President 2  3 
ANNEX 
SPECIFIC OBJECTIVES AND ACTIONS 
L  ACTIONS  ON  IMPROVEMENT  OF  INFORMATION  ON  POLLUTION-
RELATED DISEASES 
Objective:  to contribute towards a better understanding of  the role of pollutants in the 
causation and aggravation of  dis~ases in the European Community and of the 
basis and effectiveness of  preventive actions. 
1.  Establishing  priorities  for  the  identification  of those  diseases  in  which  specific 
pollutants are thought to play a role; comparing their prevalence and/or incidence and 
their relation to data on environmental factors in the different parts of the European 
Community;  examining  the  data  quality  and  identifying  where  data  are  lacking; 
analysing and reviewing data currently available on the toxicology of these pollutants, 
and  identifying  gaps  in  knowledge;  comparing  these  data,  including  methods  of 
collections, definitions and criteria used, as well as the way in which the information is 
used in analyses, in determining the actions taken and in informing the public. 
2.  Contributing to improve the comparability of data used in  preventive actions by the 
support of  exchanges of  information on pollution-related diseases and their prevention, 
including cost-benefit analysis of  the effectiveness of  actions. 
ll.  RISK  PERCEPTION  AND  RISK  MANAGEMENT  WITH  RESPECT  TO 
POLLUTION-RELATED DISEASES 
Objective:  to increase the level  of knowledge and  understanding about pollution-related 
health risks and their perception, assessment and management. 
3.  Supporting  actions  aimed  at  achieving  better  public  understanding  of risks,  their 
assessment and management; promoting work on the public perceptions of pollution-
related risks to health throughout the Community. 
4.  Promoting actions and exchanges of  information on the methods of increasing the level 
of knowledge  of the  general  public  and  opinion-formers  about  the  assessment  of 
pollution-related risks to health. 
ill.  RESPIRATORY DISEASES AND ALLERGIES 
Objective:  to  support activities  aimed  at  preventing  and  reducing the numbers  of these 
diseases. 
5.  Contributing  to the  provision  of information  to the  general  public  and  to  specific 
groups,  on  these  diseases  and  the  agents  that  play  a  role  in  them;  supporting  the 
development of ways to reinforce and link information campaigns; contributing to the 
efforts of self-help  or support  groups  active  in  the  field  of respiratory  diseases  and 
allergies. 
6.  Contributing to the comparison of various education and  training  initiatives used to 
combat  these  diseases,  with  a  view  to  promoting  best  practice;  reviewing  the 
effectiveness of  the preventive measures undertaken, including cost/benefit analyses. FINANCIAL STATEMENT 
1.  TITLE OF OPERATION 
Proposal for a European Parliament and  Council Decision adopting a programme of 
Community  action  1999-2003  on  pollution-related  diseases  in  the  context  of the 
framework for action in the field of  public health 
2.  BUDGET HEADING INVOLVED 
B3-..... 
3.  LEGAL BASIS 
Article 3(o) and Article.129 of  the Treaty establishing the European Community. 
4.  DESCRIPTION OF OPERATION 
4.1  General objective 
To contribute to achieving the objectives laid down by the Treaty: 
- under  Article  3  (  o  ),  the  Community  is  required  to  make  a  contribution  to  the 
attainment of  a high level of  health protection; 
- Article  129 requires the Community to contribute towards ensuring a high-level of 
human  health  protection,  in  particular  by  encouraging  cooperation  between  the 
Member  States,  and  if  necessary  lending  support  to.  their  action,  promoting 
coordination of their policies and  programmes,  and  fostering  cooperation with third 
countries and the competent international organisations in the sphere of public health. 
Community action is  directed towards the prevention of diseases,  in  particular major 
health scourges, by promoting research into their causes and their transmission, as well 
as health information and education. 
The general objective of  the action programme is to contribute towards ensuring a high 
level  of health  protection against  pollution-related  diseases by  improving  knowledge 
and  understanding  about  pollution-related  health  risks  and  how to address  them,  in 
particular with regard to asthma and other respiratory diseases, and allergies. 
The method for achieving this objective consists of  undertaking actions which: 
contribute  towards  a  better  understanding  of the  role  of pollutants  in  the 
causation and  aggravation of diseases in the European Community and of the 
basis and effectiveness of  preventive actions;  · 
increase  the  level  of knowledge  and  understanding  about  pollution-related 
health risks, their perception, assessment and management; 
support  activities  aimed  at  preventing  and  reducing  the  numbers  of these 
diseases. 4.2  Period covered and arrangements for renewal or extension 
5 years: 01.01.1999 to 31.12.2003 
Report  on implementation  to  be  transmitted  to  the  Council  and  European 
Parliament during the third year of  operation of  the programme. 
Report  to  the  Council  and  European  Parliament  after  completion  of the 
programme together with the results of  evaluations. 
5.  CLASSIFICATION OF EXPENDITURE OR REVENUE 
Non-compulsory expenditure 
Differentiated appropriations 
6.  TYPE OF EXPENDITURE OR REVENUE 
Subsidy for joint financing with other sources in the public and/or private sector (not 
exceeding a certain percentage of  the total cost of  the proposed projects). 
The level of funding granted depends on the scope of  the measure to be financed and 
on the extent  to which  the  action programme  is  reflected  in  the  various  activities 
planned.  Such funding  will  not  exceed  70%  of the total  budget  earmarked  for  the 
proposed projects except in the case of  networks and work ordered and of  direct use to 
the Commission, where the subsidy may amount to 100%. 
7.  FINANCIAL IMPACT 
7.1  Method of  calculating the total cost of operation (definition of unit cost) 
The method of calc:..lation is  the result  of experience acquired in  previous  activities 
related to public health. This encompasses the various types of  Community action listed 
in Table 4 of the Commission Communication (93) 559. final  of 24  November  1994, 
and  represents  extensive  experience  in  financing  cooperative  efforts  with  Member 
States as well as Non Governmental Organisations as regards collection, analysis and 
dissemination of  information, setting up networks, the establishment of  mechanisms and 
procedures of consultation  and  cooperation for  setting  common  obj.ectives  and  for 
policy  coordination  and  for  the  formulation  and  development  of  strategies  at 
Community level. 
The specific cost estimates are based on the assumption that half of  the activities to be 
·undertaken under this programme will require 100 percent funding while the other half 
will  require  50 percent funding  and  that the activities to be undertaken will  involve 
.  most or all of  the Member States. 
An amount of ECU 1.3  Million is  deemed necessary for the implementation of these 
activities for  the first  year of the  programme,  1999.  The budget framework  for  the 
subsequent  four  years  of operation  shall  be  established  by  taking  into  account  the 
Community's future financial  perspectives. The annual  allocations will  be decided  in 
accordance with the normal budgetary procedures. 3·1 
7.1.1 Improvement ofinformation on pollution-related diseases 
Reviews  on  the  data  currently  available  on  pollution-related  diseases  shall  be 
undertaken. The cost estimate for this is  100.000 ECU for the first year.  In addition, 
networks  have  to be  set  up  in  order to work on  the information  gained  by  these 
reviews. For the setting up of  networks in this context the minimum amount of  200.000 
ECU is deemed necessary. 
7.1.2 Improvement of  risk perception and risk management 
Dissemination  of information  targeted  at  the  public  and  specific  groups  such  as 
journalists has been scheduled at an average cost of200.000 ECU. In parallel actions to 
better understand public perception of pollution-related health risks shall be launched. 
For this a budget of 100.000 ECU is forseen. 
7 .1.3 Prevention of  respiratory diseases and allergies 
Support for networks to promote information on the prevention of  respiratory diseases 
and allergies in order to link information campaigns will  require an estimated cost of 
300.000 ECU in the first year. of operation of the programme. This activity shall take 
into  account  the information  gained  from  a  comparision  of various  education  and 
training  initiatives  undertaken in  order to promote best  practice.  300.000 ECU are 
planned to be spent on this. ""  _,  "'""""  "  --·-~··  .. Ql 
li 
I 
7.2  Itemized breakdown of cost (in ECU million) 
--- --
OBJECTIVE  ACTION AREA 
Establishing priorities for the identification of 
those diseases in which specific pollutants are 
thought to play a role; comparing ~heir prevalence 
and/or incidence and their relation to data on 
environmental factors in the different parts of  the 
European Community; examining the data quality 
Improvement of  and identifying where data are lacking; analysing 
information on pollution- and reviewing data currently available on the 
related diseases  toxicology of  these pollutants, and identifYing gaps 
in knowledge; comparing these data,  including 
methods of  collection, definitions and criteria used, 
as well as the way in which the information is used 
in analyses, in determining the actions taken and in 
informing the public. 
Contributing to improving the comparability of 
data used in preventive actions by the support of 
exchanges of information on pollution-related 
diseases and their prevention, including cost-
benefit analyses of  the effectiveness of  actions. 
YEARS 
1999  2000  2001  2002 
Indicative programming 
0.3 
0.1 
2003  TOTAL 
0.3 
0.1 
VJ 
(\) r-----------~----------------------- -~--~-~----
-
OBJECTIVE  ACTION AREA  YEARS 
1999  2000  2001  2002 
Supporting actions aimed at achieving better  0.2 
public understanding of  risks, their assessment and 
Risk perception and risk  management; promoting work on the public 
management  perceptions of  pollution-related risks to health 
throughout the Community. 
Promoting actions and exchanges l)f information  0.1 
on the methods of  increasing the level of 
knowledge of  the general public and opinion-
formers about the assessment of  pollution-related 
risks to health. 
Contributing to the provision of  information to the  0.3 
general public and to specific groups, on these 
diseases and the agents that play a role in them; 
supporting the development of  ways to reinforce 
Respiratory diseases 
and link information campaigns; contributing to 
the efforts of  self-help or support groups active in 
and allergies  the field of  respiratory diseases and allergies. 
Contributing to the comparison of  various  0.3 
education and training initiatives used to combat 
these diseases, with a view to promoting best 
practice; reviewing the effectiveness of  the 
preventive measures undertaken, including 
cost/benefit analyses. 
TOTAL  1.3  pm  pm  pm 
--
2003 
pm 
TOTAL 
0.2 
0.1 
)  0.3 
0.3 
~ 
1.3 
vv 
\)J 7.3  Indicative schedule of appropriations (in ECU million) 
1999  2000  2001  2002  2003  TOTAL 
Commitment  1.3 
appropriations 
Payment  -
appropriations 
1999  0.78  0.78 
2000  0.52  0.52 
2001 
I, 
2002 
2003 
Subsequent years 
TOTAL  1.3  pm  pm  pm  pm  1.3 
8.  FRAUD PREVENTION MEASURES; RESULTS OF MEASURES TAKEN 
The grant application forms  will require information on the identity and  nature of 
potential beneficiaries so that their reliability can be assessed in advance. 
Fraud prevention measures (checks, intermediate reports, final  report) are included 
in  the  agreements  or contracts  between  the  Commission  and  beneficiaries.  The 
Commission will check reports and ensure that work has been properly carried out 
before intermediate and final payments are made. 
In addition, spot checks are carried out by the Commission to verify how funds have 
been used. Checks have already been carried out in other public health budget lines 
in relation to the financial years 1991 to 1995 and have shown their effectiveness. 
9.  ELEMENTS OF COST-EFFECTIVENESS ANALYSIS 
9.1  Specific and quantifiable objectives 
The  Community  measures  aim  at  contributing  towards  ensuring  a  high  level  of 
health  protection  against  pollution-related  diseases  by  improving  knowledge. and 
understanding  about  pollution-related  health  risks  and  how  to  address  them,  in 
· particular with regard to asthma and other respiratory diseases, and allergies. 
The indicators showing whether or not objectives are achieved will include measures 
of  the following kinds. These will be redefined further in collaboration with the new 
Community programme on health monitoring whose tasks include the development 3S 
of indicators for Community public health policies.  The method for achieving this 
objective consists of  undertaking actions which : 
encourage  and  assist  the creation of networks  that  cbntribute  towards  a 
better· understanding  of the  role  of  pollutants  in  the  causation  and 
aggravation of diseases in the European Community;  and of the basis and 
effectiveness  of  preventive  actions  (membership,  production  of  e.g. 
information bulletins, conferences, www-discussion groups etc.);  · 
·  disseminate information about pollution-related health risks, their perception, 
assessment and management; 
improve information and  data on pollution-related diseases. at  Community 
level and the prevalence and/or incidence rates of  these diseases 
foster consultation and cooperation between Member States (description of 
cases of  such consultation etc.) and 
help public health bodies assisted in making better use of other Community 
policies in their efforts aiming at the prevention of  pollution-related diseases. 
Target Population 
1.  Competent health authorities of  the Member States, at national, regional and 
local level and competent international organisations in the sphere of public 
health; 
2.  Health  professionals,  health  epidemiological  services,  health  and  medical 
associations, academic institutions etc; 
3.  NGO's  and  other bodies  interested  in  health  matters,  and  the  public  in 
general. 
9.2  Grounds for the operation 
In initiating  action  under  Article  129,  the  Community  has  to  address  itself to 
preventing diseases and protecting health. The Commission's communication on the 
framework for action in the field for public health (COM(93) 559 final of 23.11.93) 
sets out criteria on which to determine priority areas for Community programmes. In 
accordance with these criteria, the 1993 "framework" communication evaluated the 
different  options  for  addressing  diseases,  in  particular  major  scourges  and  their 
underlying causes, by various types of  Community actions and retained on the basis 
of  criteria listed in that communication, eight priority areas of  which the prevention 
of  pollution-related diseases was one. 
In its Resolution of  11  November 1991  the Council and the Ministers for Health of 
the Member States, meeting within the Council,  invited the Commission,  in  close 
cooperation with the competent authorities of  the Member States, to take stock of 
the knowledge and experience available in the Member States, the Community and 
international  organizations  regarding  the  relationship  between  health  and  the 
environment. 
In its Resolution A4-0311/95 on the Medium-Term Social Action Programme 1995-
1997 the Parliament asked the Commission to present, under the proper procedures, 
the action programme on pollution-related diseases foreseen  in  the Commission's 
framework communication. 
The  programme  aims  at  bringing  about  an  accelerated  and  effective  sharing  of 
information  and  experience,  Community  wide  understanding  of key  issues  and 
questions  on  tackling  pollution-related  diseases,  and  increased  cooperation  of 
Member States so  as to avoid  unnecessary duplication of work and  speed up the 
adoption of  best solution to problems common to Member States concerning such 
.. 36 
diseases.  This input envisaged for the Community and the Commission by Article 
129 provides a clear common framework of  rules. This would be substantially more 
effective than leaving such questions to inter-governmental co-operation without a 
Community contribution. 
As regards the intervention methods and the allocation of  funds,  the following will 
apply:  · 
specific application of  the principle of  subsidiarity when identifying measures 
to be undertaken and co-financed; 
identification  and  selection  of projects  for  co-financing  in  the  fields  of 
pollution-related diseases 
the concept of  added Community value, which will continue to be realised in 
particular through the coordination of national measures,  the dissemination 
of  information  and  experiences,  the  establishment  of  priorities,  the 
development of networking as appropriate,  selection of European projects 
and the motivation and mobilisation of  all involved. 
Two methods will  be employed to implement the programme.  One is  to support 
projects carried out in Member States and at the Community level.  The selection of 
priority  projects  is  based  largely  on  general  and  intermediate  objectives,  and 
implementation of  the measures themselves depends on the quality and effectiveness 
of projects submitted to the competent department during the course of the year. 
The other is to undertake specific activities necessary to achieve the objectives of 
the programme, which will be fully financed by the programme. 
The selection criteria for projects are as follows: 
Compatibility with the objectives  and  conformity with at least one of the 
established objectives; 
Examination of  the "added Community value" of the projects (transnational 
participation,  development of a model  applicable in  other Member States, 
information usable in other Member States, etc.);  · 
Presumed effectiveness and profitability; 
Clarity and justification of  requirements; 
Relevance of  selected methodology; 
Organizational competence and experience; 
Suitability of  budget for objectives; 
Support for projects from national partners; 
Objective assessment; 
Opinion of  the advisory committee involved. 
The budget proposed for this programme, of 1.3  MECU for the first  year of this 
programme,  matches  that  proposed at the same  time  for  the Community  action 
programmes on rare diseases and injury prevention. This reflects the equal priority 
attached to these fields for action determined by the Commission Communication on 
the framework for action in the field  of public health (1993), an evaluation which 
remains valid today. The amount proposed represents the bare minimum required to 
start the programme. j 
9.3  Monitoring and evaluation of the operation 
9.3.1  Monitoring ofthe operation 
Monitoring at the Community level is to be carried out by the Commission, 
which  will  submit  a  report  half-way  through  the  implementation  of the 
programrile,  and  a  final  report  after  its  completion  to  the  Council,  the 
European Parliament, the Economic and Social Committee, and 
the Committee of the Regions,  drawing from  national  reports  as  well  as 
evaluations of  the actions under the programme and of  individual projects.  · 
9.3.2  Evaluation 
Evaluation will be by means of: 
An  evaluation  of the  main  measures  and  of subsidised  projects 
involving, where necessary, the participation of  independent experts; 
An evaluation report during the third year, 
An  overall  report  on  the  quality  and  effectiveness  of projects 
implemented  under  the  action  plan,  to  be  submitted  by  the 
Commission to the other Community institutions after completion of 
the programme. 
Performance indicators selected for this evaluation: 
Evaluation  of  projects  by  Commission  · 6fficials  and/or  those 
cooperating with them; 
Analysis of  intermediate reports on measures scheduled and financed, 
allowing a shifting of  emphasis where possible; 
Impact studies by external bodies 
Relevance of  the methodology used by organizers; 
Suitability of  the budget for the objectives; 
Skills and experience of  bodies; 
Dissemination of  results; 
Evaluation procedures and intervals: 
Drawing up of  intermediate and final reports on the various measures 
undertaken in the field; 
Development of a "standard" evaluation form for the measure, to be 
forwarded by the beneficiaries with their final  reports, and checking 
of these documents by officials either at the Commission or in  the 
field. 10.  ADMINISTRATIVE EXPENDITURE (PART A OF THE BUDGET) 
Actual mobilisation of  the necessary administrative resources will be conditioned by 
the Commission's annual  decision on the allocation of resources,  having  regard in 
particular to additional staff and funds provided by the budgetary authority. 
10.1  Impact on the number of employees 
Types of employees  Staff carrying out action  Source of employees  Duration 
pennanent  temporary  from within DG  supplementary staff 
employees  employees  or service 
Officials or  A·  1  0  1  0 
temporary agents  B  l  0  1  0 
c  1  0  l  0 
Other resources 
Total  3  0 
10.2  Financial impact of supplementary staff 
No supplementary staff are envisaged 
3  0 
10.3  Increase in other running costs arising from the action 
Budget line  Amounts  Method of  calculation 
Meetings A251 0  104,250 ecus  2 meetings of  advise~  committee/~·~ar, 
1 representative/M:em  er State=  J 
2 meetings/year x 15 refrs x 695 
ecuslreprs  x 5 years=  04,250 ecus 
The  resources  necessary  to  cover  the  expenditure  below  for  the  5-year  period  will  be 
obtained  by  re-deployment  of existing  financial  resources  and  the  use  of supplementary 
resources will not be required. 
a) Personnel Expenses (Title A1, A2 and AS) 
3 x 100,000 ecus x 5 years= 1,500,000 ecus 
b) Operational Expenses 
Expenses for meetings (A-250) 
2 meetings/year x 1)  experts x 825 ecus/expert  x 5 years= 123,750 ecus 
Expenses for travel (A-130)  · 
24 m!ss!ons/year Brussels-Luxembourg x 200 ecu~IT!ission x 5 years = 24"' 000 ecus 
30 mtsstonsfyear to Member States X  rooo ecus/mtsston X 5 years=  150,u00 ecus 
c) Total:  1,797,750 ecus 39 
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